Skip Navigation

Patent Detail: Aryl Hydrocarbon Receptor (AHR) Modifiers as Novel Cancer Therapeutics

Maintenance notice: We are currently addressing issues with broken links due to recent major website changes. We apologize for any inconvenience and appreciate your patience. Please contact brittany.trottier@niehs.nih.gov for assistance.

Patent Detail

Superfund Research Program

Aryl Hydrocarbon Receptor (AHR) Modifiers as Novel Cancer Therapeutics

Number: CPA No 2807199 & PCT Application No US 2011/045526
Year: 2011
Patent Status: Pending
Authors: Sherr, D.H., M.P. Pollastri, J.J. Schlezinger, S. Haigh Molina, S. Schaus, J.R. Giguere

Associated Projects:

  • Boston University: Environmental PPARγ Pathway Activators: Multifaceted Metabolic Disruptors Impacting Adipose and Bone Homeostasis
Back
to Top